AKAM
42
2
NI
70
2
SYY
47
-2
PAYX
53
2
NWSA
78
3
AMT
46
3
MUR
31
2
CVX
44
3
AA
34
-3
APA
34
2
AEE
76
-5
MAT
37
-9
MAR
54
12
CME
64
3
LOW
55
2
CNX
44
2
IBM
50
2
HES
52
2
VRSK
63
2
FOX
55
2
AKAM
42
2
NI
70
2
SYY
47
-2
PAYX
53
2
NWSA
78
3
AMT
46
3
MUR
31
2
CVX
44
3
AA
34
-3
APA
34
2
AEE
76
-5
MAT
37
-9
MAR
54
12
CME
64
3
LOW
55
2
CNX
44
2
IBM
50
2
HES
52
2
VRSK
63
2
FOX
55
2
Financhill
Back

Repligen Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

RGEN
Repligen

Last Price:
$144.86
Seasonality Move:
3.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 17.3% based on the past 38 years of stock performance.
  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $144.75. The Score for RGEN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 17.3% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
42
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
182.52
52-Week Low:
102.97

Prediction Charts

Market Cap:
8.1B
Price in USD:
144.75
Volume:
439.7K
Beta:
0.99

Technical Analysis

SMA50:
141.18
SMA100:
148.22
SMA200:
145.41
52-Wk Change:
-12.62%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 144.75 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 105.78 116.09 121.84 102.97
Apr-8 121.79 108.92 122.69 105.76
Apr-9 106.89 123.85 124.38 105.06
Apr-10 121.10 115.19 121.10 110.97
Apr-11 115.37 122.86 123.24 111.21
Apr-14 126.30 127.26 128.93 123.50
Apr-15 126.04 126.62 130.31 123.97
Apr-16 127.90 132.10 135.81 127.90
Apr-17 131.26 130.00 131.51 125.24
Apr-21 129.43 131.64 132.41 125.05
Apr-22 138.51 138.93 141.62 136.07
Apr-23 144.46 141.40 148.94 140.70
Apr-24 141.81 145.23 145.91 140.70
Apr-25 143.75 144.75 145.96 140.89

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.07 per share, an increase this year of $0.17 per share, and an increase next year of $0.48 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.